The content on this site is intended for healthcare professionals only
Dr George Follows speaks with ecancertv at BSH 2016 about the UKCLL session he chaired, reviewing the data presented, the background, and potential clinical applications of current research.
He describes the microenvironment required to sustain CLL in research, having previously been difficult to model and maintain cancer cells in situ.
More of about the microenvironment in vivo is discussed by Dr Jan Burger here.
For ongoing trials in the UK, you can view more from Dr Follows here.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Overview of the management of HER2-low breast cancer patients
Molecular profiling in prostate cancer: key challenges for clinical implementation
